Colorado MEDtech bought by investment firm for $62.5 million
This article was originally published in Clinica
Executive Summary
A long drawn-out period of uncertainty has come to an end for Colorado MEDtech, which has reached an agreement to be bought for $62.5m by local private equity investment firm KRG Capital Partners. The buyer says it is committed to Colorado MEDtech's ultrasound accessories and minimally invasive surgical products, which are managed by its CIVCO Medical Instruments subsidiary.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.